Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

CT scanner and digital imagery © SHUTTERSTOCK

NDORMS was one of the organisations to receive the funding, as part of a partnership with Zebra Medical Vision and in collaboration with The Royal Osteoporosis Society, and the University of Cambridge. The award was announced by the Secretary of State for Health, Matt Hancock on 16 June. The AI Award is making £140 million available over four years to accelerate the testing and evaluation of artificial intelligence technologies which meet the aims set out in the NHS Long Term Plan.

Kassim Javaid, Associate Professor at NDORMS, is co-lead for the multi-centre project using AI to analyse any CT scan to catch undiagnosed spinal fractures, which can be a marker for osteoporosis.

Patients will be directed to fracture prevention programmes, where they will receive lifestyle advice, and medications where appropriate, to reduce future fracture risks associated with the disease.

The award allows the team to test this AI-enabled pathway in five different hospitals and study how the technology impacts patients' health and protects them from fractures. It takes it one step closer to being used in the NHS to benefit patients and provide life-changing treatment.

Kassim said: "As the co-lead from NDORMS at the University of Oxford, I am excited to use our team's research skills and expertise to provide the critical information for the NHS to implement this AI technology for the benefit of 100,000s of patients every year, offering medicines to protect their bones and maintain a healthy independent life."

"This grant is another milestone in our path towards a fully comprehensive and scalable AI solution for population health domains. This prestigious grant is joining our R&D collaboration with NHS Greater Glasgow & Clyde to co-develop AI-enabled osteoporosis prevention services," says Zohar Elhanani, CEO of Zebra Medical Vision. "We're honored to be chosen by the NHS time after time and are thankful for the opportunity to demonstrate our groundbreaking technology in the areas of vertebral fractures for the benefit of the broader population."

The AI Award is one of the programmes that make up the NHS AI Lab, led by NHSX and delivered in partnership with the Accelerated Access Collaborative (AAC) and National Institute for Health Research (NIHR).

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.